The success of lipid nanoparticles (LNPs) in treating COVID-19 promotes further research of
mRNA vaccines for cancer vaccination. Aiming at overcoming the constraints of currently …

Messenger RNA (mRNA) has recently become a compelling alternative for treating and
preventing cancers with substantial therapeutic outcomes. In vitro transcription of mRNA has …

mRNA, as one of the foci of biomedical research in the past decade, has become a
candidate vaccine solution for various infectious diseases and tumors and for regenerative …

The effectiveness of messenger RNA (mRNA) vaccines, especially those designed for
COVID-19, relies heavily on sophisticated delivery systems that ensure efficient delivery of …

Messenger RNA (mRNA)-based vaccines have shown promise against infectious diseases
and several types of cancer in the last two decades. Their promise can be attributed to their …

Abstract mRNA vaccines have been increasingly recognized as a powerful vaccine platform
since the FDA approval of two COVID-19 mRNA vaccines, which demonstrated outstanding …

Messenger RNA (mRNA) has received great attention in the prevention and treatment of
various diseases due to the success of coronavirus disease 2019 (COVID‐19) mRNA …

Vaccination represents the best line of defense against infectious diseases and is crucial in
curtailing pandemic spread of emerging pathogens to which a population has limited …

Abstract mRNA vaccines have been revolutionary in terms of their rapid development and
prevention of SARS-CoV-2 infections during the COVID-19 pandemic, and this technology …

In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor
immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great …